PPARG is reported to function as an oncogene in ESCC and the activation of PPARG suppresses cell proliferation and induces cell apoptosis of esophageal cancer cells by inhibiting the TLR‐4 dependent mitogen‐activated protein kinase pathway 33. This evidence concerns the gene TLR4 and esophageal cancer.